R
Relay Therapeutics, Inc.
RLAY · NASDAQ · Healthcare · 4.4B
Closing price
$17.88
+2.70% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
5.4×
Enterprise value / EBITDAEV/EBITDA
-11.1×
Free cash flow yieldFCF yield
-7.7%
Return on equityROE
-48.8%
Operating margin
-1971.6%
Net debt / EBITDAbalance-sheet strength
0.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.